Skip to content

The comparison of effectiveness of Cinal-f and Gonal-f in IVF cycles in patients referring to vali-e asr reproductive health research center

The comparison of effectiveness of Cinal-f and Gonal-f in IVF cycles in patients referring to vali-e asr reproductive health research center

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201011155181N1
Enrollment
200
Registered
2011-01-03
Start date
2011-04-09
Completion date
Unknown
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female Infertility. Female infertility

Interventions

Intervention 1: Intervention group: Cinal-F, 150units, is injected subcutaneously, on the 2nd day of the cycle. The protocol is long-acting suppression with superfact. HCG 10000u is injected when ther

Sponsors

Cinajen Company
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: Age less than35 years FSH in the 2 date of cycle less than or equal to8.3 regularity of menses long protocol for suppression of hypothesis

Exclusion criteria

Exclusion criteria: smoking history of any operation of ovary sensitivity to Gonal–f or Cinal-f Abnormal hormonal profiles History of ovarian hyper stimulation Tumors of sex organs Uncontrolled insufficiency of thyroid or adrenal

Design outcomes

Primary

MeasureTime frame
Percentage of metaphase II oocytes. Timepoint: The oocyte retrieval day. Method of measurement: Based on embryologist assessment.

Secondary

MeasureTime frame
Evaluation of oocyte MetaphaseI. Timepoint: At the day of OPU. Method of measurement: By the embryologist.;Evaluation of Polar Body. Timepoint: At the day of OPU. Method of measurement: By the embryologist.;Evaluation of atretic oocyte. Timepoint: At the day of OPU. Method of measurement: By the embryologist.;Evaluation of Germinal Vesicle. Timepoint: At the day of OPU. Method of measurement: By the embryologist.;Evaluation of Zona Plucida appearance. Timepoint: At the day of OPU. Method of measurement: By the embryologist.;Number of follicle stimulating hormone (FSH) vials used during stimulation. Timepoint: The oocyte retrieval day. Method of measurement: Counting of vials.;Embryo quality. Timepoint: 2-3 days after oocytes fertilization. Method of measurement: Based on embryologist assessment.;• Duration of Follicle stimulating hormone ( FSH) stimulation. Timepoint: The end of ovarian stimulation. Method of measurement: Counting of stimulation days.;Number of embryos replaced or frozen. Timepoint: 2-3 days after oocytes fertilization. Method of measurement: Counting of replaced or frozen embryos.;Number of clinical pregnancies. Timepoint: After 5-8 weeks of gestation. Method of measurement: Visualization of one or more gestational sacs in the sonography.;Number of ongoing pregnancies. Timepoint: After =20 completed weeks of gestation. Method of measurement: Detection of fetus with heart activity beyond 20 weeks of gestation by sonography.;The incidence of ovarian hyper stimulation syndrome(OHSS). Timepoint: Throughout the study. Method of measurement: Base on physician assessment according to OHSS diagnosis criteria.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBatool Hossein Rashidi

Tehran University of Medical Sciences

bhrashidi@gmail.com+98 21 6658 1616

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026